Cargando…

Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics

IMPORTANCE: To prevent blindness, repeated infant eye examinations are performed to detect severe retinopathy of prematurity (ROP), yet only a small fraction of those screened need treatment. Early individual risk stratification would improve screening timing and efficiency and potentially reduce th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivodic, Aldina, Hård, Anna-Lena, Löfqvist, Chatarina, Smith, Lois E. H., Wu, Carolyn, Bründer, Marie-Christine, Lagrèze, Wolf A., Stahl, Andreas, Holmström, Gerd, Albertsson-Wikland, Kerstin, Johansson, Helena, Nilsson, Staffan, Hellström, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865304/ https://www.ncbi.nlm.nih.gov/pubmed/31697330 http://dx.doi.org/10.1001/jamaophthalmol.2019.4502

Ejemplares similares

Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial
por: Pivodic, Aldina, et al.
Publicado: (2022)

Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity
por: Pivodic, Aldina, et al.
Publicado: (2022)

Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity: Development and Validation of the Revised DIGIROP Clinical Decision Support Tool
por: Pivodic, Aldina, et al.
Publicado: (2023)

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021)

Validation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) using retrospective clinical data
por: Pivodic, Aldina, et al.
Publicado: (2020)

Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort
por: Pivodic, Aldina, et al.
Publicado: (2023)

WINROP Identifies Severe Retinopathy of Prematurity at an Early Stage in a Nation-Based Cohort of Extremely Preterm Infants
por: Lundgren, Pia, et al.
Publicado: (2013)

Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity
por: Lundgren, Pia, et al.
Publicado: (2017)

Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
por: Hellström, Ann, et al.
Publicado: (2021)

Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)

Low Birth Weight Is a Risk Factor for Severe Retinopathy of Prematurity Depending on Gestational Age
por: Lundgren, Pia, et al.
Publicado: (2014)

Association between low fatty acid levels and platelet count in infants with Retinopathy of Prematurity
por: Lundgren, Pia, et al.
Publicado: (2020)

Correspondence to “Prediction of severe retinopathy of prematurity in 24–30 weeks gestation infants using birth characteristics”
por: Pivodic, Aldina, et al.
Publicado: (2021)

Costs associated with retinopathy of prematurity: a systematic review and meta-analysis
por: Gyllensten, Hanna, et al.
Publicado: (2022)

Association of Retinopathy of Prematurity With Low Levels of Arachidonic Acid: A Secondary Analysis of a Randomized Clinical Trial
por: Löfqvist, Chatarina A., et al.
Publicado: (2018)

Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
por: Lund, Anna‐My, et al.
Publicado: (2019)

Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
por: Hellgren, Gunnel, et al.
Publicado: (2021)

Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
por: Hellgren, Gunnel, et al.
Publicado: (2017)

IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
por: Cakir, Bertan, et al.
Publicado: (2020)

Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity
por: Nilsson, Anders K., et al.
Publicado: (2021)

Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm children
por: Kistner, Anna, et al.
Publicado: (2014)

Development of a quality improvement package for reducing sight-threatening retinopathy of prematurity
por: Kumar, Praveen, et al.
Publicado: (2020)

Understanding and managing sight-threatening diabetic retinopathy
por: Yorston, David
Publicado: (2023)

WINROP algorithm for prediction of sight threatening retinopathy of prematurity: Initial experience in Indian preterm infants
por: Sanghi, Gaurav, et al.
Publicado: (2018)

Retinopathy of prematurity: Metabolic risk factors
por: Fu, Zhongjie, et al.
Publicado: (2022)

On the use of antiangiogenetic medications for retinopathy of prematurity
por: Hård, Anna-Lena, et al.
Publicado: (2011)

Early management of sight threatening retinopathy in incontinentia pigmenti
por: Michel, Sarah, et al.
Publicado: (2020)

Retinopathy of prematurity: the need for prevention
por: Liegl, Raffael, et al.
Publicado: (2016)

Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial
por: Sjöbom, Ulrika, et al.
Publicado: (2023)

Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial
por: Najm, Svetlana, et al.
Publicado: (2017)

Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
por: Mamtora, Sunil, et al.
Publicado: (2016)

Review of the management of sight-threatening diabetic retinopathy during pregnancy
por: Choo, Priscilla Peixi, et al.
Publicado: (2021)

High rate and large intercentre variability in retreatment of retinopathy of prematurity in infants born <24 gestational weeks
por: Lundgren, Pia, et al.
Publicado: (2021)

Ranibizumab in retinopathy of prematurity – one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study
por: Stahl, Andreas, et al.
Publicado: (2022)

Longitudinal Serum Metabolomics in Extremely Premature Infants: Relationships With Gestational Age, Nutrition, and Morbidities
por: Nilsson, Anders K., et al.
Publicado: (2022)

Associations between vitamin D status and sight threatening and non-sight threatening diabetic retinopathy: a systematic review and meta-analysis
por: Trott, Mike, et al.
Publicado: (2022)

Association Between Gut Microbial Abundance and Sight-Threatening Diabetic Retinopathy
por: Khan, Rehana, et al.
Publicado: (2021)

Metabolism in Retinopathy of Prematurity
por: Tomita, Yohei, et al.
Publicado: (2021)

A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy
por: Stratton, Irene M., et al.
Publicado: (2013)

Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy
por: Gurudas, Sarega, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5lnkb44l8n3ma8epjnvg3bhqlf